Quick Answer
BALCHEM CORP reported Research And Development Expense of $18.51 million for the year ending 2025.
- BALCHEM CORP showed an increase of +10.2% in Research And Development Expense from 2024 to 2025.
- This data is from BALCHEM CORP's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), BALCHEM CORP's Research And Development Expense has grown by 461.2%.
- Historical annual values: Fiscal year 2025: $18.51 million | Fiscal year 2024: $16.79 million | Fiscal year 2023: $15.05 million | Fiscal year 2022: $12.19 million | Fiscal year 2021: $13.52 million | Fiscal year 2020: $10.33 million | Fiscal year 2019: $11.38 million | Fiscal year 2018: $11.59 million | Fiscal year 2017: $9.31 million | Fiscal year 2016: $7.33 million | Fiscal year 2015: $5.99 million | Fiscal year 2014: $4.81 million | Fiscal year 2013: $3.62 million | Fiscal year 2012: $3.42 million | Fiscal year 2011: $2.89 million | Fiscal year 2010: $3.19 million | Fiscal year 2009: $3.30 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: